209 related articles for article (PubMed ID: 24998852)
21. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
Vega FM; Sevilla A; Lazo PA
Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
[TBL] [Abstract][Full Text] [Related]
22. Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression.
López-Peláez M; Soria-Castro I; Boscá L; Fernández M; Alemany S
Eur J Immunol; 2011 Jun; 41(6):1733-41. PubMed ID: 21469113
[TBL] [Abstract][Full Text] [Related]
23. Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an Ikappa-B Kinase-beta-dependent pathway and is required for Tpl2 activation by external signals.
Cho J; Melnick M; Solidakis GP; Tsichlis PN
J Biol Chem; 2005 May; 280(21):20442-8. PubMed ID: 15778223
[TBL] [Abstract][Full Text] [Related]
24. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
den Besten W; Kuo ML; Williams RT; Sherr CJ
Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
[TBL] [Abstract][Full Text] [Related]
25. Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis.
Decicco-Skinner KL; Trovato EL; Simmons JK; Lepage PK; Wiest JS
Oncogene; 2011 Jan; 30(4):389-97. PubMed ID: 20935675
[TBL] [Abstract][Full Text] [Related]
26. Polyamine depletion induces nucleophosmin modulating stability and transcriptional activity of p53 in intestinal epithelial cells.
Zou T; Rao JN; Liu L; Marasa BS; Keledjian KM; Zhang AH; Xiao L; Bass BL; Wang JY
Am J Physiol Cell Physiol; 2005 Sep; 289(3):C686-96. PubMed ID: 15872011
[TBL] [Abstract][Full Text] [Related]
27. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
Li Z; Boone D; Hann SR
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
[TBL] [Abstract][Full Text] [Related]
28. PICT-1 is a key nucleolar sensor in DNA damage response signaling that regulates apoptosis through the RPL11-MDM2-p53 pathway.
Chen H; Han L; Tsai H; Wang Z; Wu Y; Duo Y; Cao W; Chen L; Tan Z; Xu N; Huang X; Zhuang J; Huang L
Oncotarget; 2016 Dec; 7(50):83241-83257. PubMed ID: 27829214
[TBL] [Abstract][Full Text] [Related]
29. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis.
Koliaraki V; Roulis M; Kollias G
J Clin Invest; 2012 Nov; 122(11):4231-42. PubMed ID: 23064365
[TBL] [Abstract][Full Text] [Related]
30. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
Lee JH; Kim HS; Lee SJ; Kim KT
J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
[TBL] [Abstract][Full Text] [Related]
31. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis.
Bischof D; Pulford K; Mason DY; Morris SW
Mol Cell Biol; 1997 Apr; 17(4):2312-25. PubMed ID: 9121481
[TBL] [Abstract][Full Text] [Related]
32. The tyrosine kinase Syk regulates TPL2 activation signals.
Eliopoulos AG; Das S; Tsichlis PN
J Biol Chem; 2006 Jan; 281(3):1371-80. PubMed ID: 16291755
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA).
Ouyang T; Bai RY; Bassermann F; von Klitzing C; Klumpen S; Miething C; Morris SW; Peschel C; Duyster J
J Biol Chem; 2003 Aug; 278(32):30028-36. PubMed ID: 12748172
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
35. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
37. Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.
Lee WJ; Lan KH; Chou CT; Yi YC; Chen WC; Pan HC; Peng YC; Wang KB; Chen YC; Chao TH; Tien HR; Sheu WH; Sheu ML
Neoplasia; 2013 Sep; 15(9):1036-48. PubMed ID: 24027429
[TBL] [Abstract][Full Text] [Related]
38. Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.
Melnikova VO; Santamaria AB; Bolshakov SV; Ananthaswamy HN
Oncogene; 2003 Sep; 22(38):5958-66. PubMed ID: 12955074
[TBL] [Abstract][Full Text] [Related]
39. HDM2 phosphorylation by MAPKAP kinase 2.
Weber HO; Ludwig RL; Morrison D; Kotlyarov A; Gaestel M; Vousden KH
Oncogene; 2005 Mar; 24(12):1965-72. PubMed ID: 15688025
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.
Cho J; Tsichlis PN
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2350-5. PubMed ID: 15699325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
